ConductScience.org, home

Paper34512640

Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.

Hu M and 7 others. Front Immunol, 2021. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings. Papers, record 34512640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34512640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2021-12-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu MMin
2Rogers NMNatasha M
3Li JJennifer
4Zhang GYGeoff Y
5Wang YMYuan Min
6Shaw KKarli
7O'Connell PJPhilip J
8Alexander SIStephen I

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epitopes, T-LymphocyteMajor topic
Immune ToleranceMajor topic
Kidney TransplantationMajor topic
T-Lymphocytes, RegulatoryMajor topic
Allografts
Animals
Bone Marrow Transplantation
Clinical Trials as Topic
Cytokines
HLA Antigens
Humans
Models, Animal
Treatment Outcome

Source PubMed

Download CSV of topics

References130

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118846251Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.J Clin Invest2008https://conductscience.org/library/papers/18846251PubMed
222491420CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis.J Am Soc Nephrol2012https://conductscience.org/library/papers/22491420PubMed
329201599Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance.Curr Transplant Rep2017https://conductscience.org/library/papers/29201599PubMed
42136906Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.J Exp Med1990https://conductscience.org/library/papers/2136906PubMed
525824574IL-17 deficiency attenuates allograft injury and prolongs survival in a murine model of fully MHC-mismatched renal allograft transplantation.Am J Transplant2015https://conductscience.org/library/papers/25824574PubMed
614726386Transplantation tolerance induced by intranasal administration of HY peptides.Blood2004https://conductscience.org/library/papers/14726386PubMed
725452562
Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
J Immunol2015https://conductscience.org/library/papers/25452562PubMed
830429370Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.JCI Insight2018https://conductscience.org/library/papers/30429370PubMed
929980618Revisiting IL-2: Biology and therapeutic prospects.Sci Immunol2018https://conductscience.org/library/papers/29980618PubMed
1024354870Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.Am J Transplant2014https://conductscience.org/library/papers/24354870PubMed
1129497427Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.Front Immunol2018https://conductscience.org/library/papers/29497427PubMed
1220702778The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Blood2010https://conductscience.org/library/papers/20702778PubMed
1333658995Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.Front Immunol2020https://conductscience.org/library/papers/33658995PubMed
1433125206A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report.Transplantation2020https://conductscience.org/library/papers/33125206PubMed
1512522256Control of regulatory T cell development by the transcription factor Foxp3.Science2003https://conductscience.org/library/papers/12522256PubMed
1611673485Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity.J Immunol2001https://conductscience.org/library/papers/11673485PubMed
1718827184
CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
Blood2009https://conductscience.org/library/papers/18827184PubMed
1820875655Cardiac allograft acceptance induced by blockade of CD40-CD40L costimulation is dependent on CD4+CD25+ regulatory T cells.Surgery2011https://conductscience.org/library/papers/20875655PubMed
1917130784Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.Transplantation2006https://conductscience.org/library/papers/17130784PubMed
2028222739Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression.J Transl Med2017https://conductscience.org/library/papers/28222739PubMed

See all 130 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42985516Antigen-specific regulatory cell therapy approaches in kidney transplantation.Front Immunol2026https://conductscience.org/library/papers/42985516PubMed
42358982CD25+CD27+CD70- alloantigen-specific Tregs: promising stable immunotherapy for transplantation.Front Immunol2026https://conductscience.org/library/papers/42358982PubMed
41133815Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41133815PubMed
40936404Regulatory T cell therapy in solid organ transplantation: clinical applications and laboratory monitoring strategies.Clin Transplant Res2025https://conductscience.org/library/papers/40936404PubMed
40558103Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?Antibodies (Basel)2025https://conductscience.org/library/papers/40558103PubMed
39850891ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IκBα/cRel pathway.Front Immunol2024https://conductscience.org/library/papers/39850891PubMed
38516885Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance.JCI Insight2024https://conductscience.org/library/papers/38516885PubMed
38426492A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models.J Clin Invest2024https://conductscience.org/library/papers/38426492PubMed
37874660Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.JCI Insight2023https://conductscience.org/library/papers/37874660PubMed
37629531Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives.Life (Basel)2023https://conductscience.org/library/papers/37629531PubMed
36675265Treg Therapy for the Induction of Immune Tolerance in Transplantation-Not Lost in Translation?Int J Mol Sci2023https://conductscience.org/library/papers/36675265PubMed
36599351Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance.Cell Rep Med2023https://conductscience.org/library/papers/36599351PubMed
36311730Complement-targeted therapies in kidney transplantation-insights from preclinical studies.Front Immunol2022https://conductscience.org/library/papers/36311730PubMed
36009272Ozone Pollution, Oxidative Stress, Regulatory T Cells and Antioxidants.Antioxidants (Basel)2022https://conductscience.org/library/papers/36009272PubMed
35955623Wasabi Component 6-(Methylsulfinyl)hexly Isothiocyanate and Derivatives Improve the Survival of Skin Allografts.Int J Mol Sci2022https://conductscience.org/library/papers/35955623PubMed
35874735Cellular Immune Responses in Islet Xenograft Rejection.Front Immunol2022https://conductscience.org/library/papers/35874735PubMed
35720402Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.Front Immunol2022https://conductscience.org/library/papers/35720402PubMed
35146940Light-Controllable Binary Switch Activation of CAR T Cells.ChemMedChem2022https://conductscience.org/library/papers/35146940PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34512640

GET https://conductscience.org/api/papers/v1/34512640/references?page=2